White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model
Open Access
- 21 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroinflammation
- Vol. 17 (1), 1-18
- https://doi.org/10.1186/s12974-020-1698-7
Abstract
Background Metabolic syndrome, the development of which is associated with high-caloric Western diet (HCD) intake, represent a risk factor for mild cognitive impairment (MCI) and dementia including Alzheimer's disease (AD) later in life. This study aimed to investigate the effect of diet-induced metabolic disturbances on white matter neuroinflammation and cognitive function in a transgenic (TG) Fischer 344 rat carrying a human beta-amyloid precursor protein (APP) gene with Swedish and Indiana mutations (APP21 TG), a model of pre-AD and MCI. Methods TG and wildtype (WT) rats received either a HCD with 40% kJ from fat supplemented with 20% corn syrup drink or a standard diet for 12 weeks. Body weight, caloric intake, and blood pressure were measured repeatedly. End-point changes in glucose and lipid metabolism were also assessed. Open field task was used for assessment of activity; Morris water maze was used to assess spatial learning and memory. Cerebral white matter microglia and astrocytes, hippocampal neurons, and neuronal synapses were examined using immunohistochemistry. Results Rats maintained on the HCD developed significant obesity, visceral adiposity, dyslipidemia, and hyperinsulinemia, but did not become hypertensive. Impaired glucose tolerance was observed only in WT rats on the HCD. Total microglia number, activated OX-6+ microglia, as well as GFAP+ astrocytes located predominantly in the white matter were greater in the APP21 TG rat model in comparison to WT rats. HCD-driven metabolic perturbations further exacerbated white matter microgliosis and microglia cell activation in the APP21 TG rats and led to detectable changes in spatial reference memory in the comorbid prodromal AD and metabolic syndrome group compared to WT control rats. Neuronal density in the CA1 subregion of the hippocampus was not different between the experimental groups. Synaptic density in the CA1 and CA3 hippocampal subregions was lower in the TG rats compared to WT rats; however, there was no additional effect of the co-morbidity on this measure. Conclusions These results suggest that white matter neuroinflammation might be one of the possible processes of early interaction of metabolic syndrome with MCI and pre-AD and could be one of the early brain pathologies contributing to cognitive deficits observed in mild cognitive impairment and dementia, including AD cases.Funding Information
- Canadian Institutes of Health Research (R1478A47)
- Canadian Consortium on Neurodegeneration in Aging (CCNA team grant)
This publication has 66 references indexed in Scilit:
- White matter dementiaTherapeutic Advances in Neurological Disorders, 2012
- Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic ratsJournal of Neurochemistry, 2011
- Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediatorsJournal of Neurochemistry, 2010
- Metabolic Effects of Fructose and the Worldwide Increase in ObesityPhysiological Reviews, 2010
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s diseaseJournal of Neurochemistry, 2008
- Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specificallyBMC Neuroscience, 2008
- Amiloride-sensitive channels in type I fungiform taste cells in mouseBMC Neuroscience, 2008
- Microglial activation in white matter lesions and nonlesional white matter of ageing brainsNeuropathology and Applied Neurobiology, 2007
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991